logo
logo

Dermaliq Therapeutics Locks In $15M Series A

Dermaliq Therapeutics Locks In $15M Series A

01/18/22, 4:05 PM
Money raised
$15 million
Round Type
series a
Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.

Company Info

Company
Dermaliq Therapeutics